Ticker
MYGNCompany Name
MYRIAD GENETICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -1.06% | $ 527.56M | $ 5.6M |
3/31/2025 | -1.5% | $ 393.6M | $ 5.9M |
12/31/2024 | -0.6% | $ 979.75M | $ 5.9M |
9/30/2024 | -7.99% | $ 1.58B | $ 126.6M |
6/30/2024 | -5.23% | $ 2.42B | $ 126.6M |
3/31/2024 | -5.7% | $ 2.17B | $ 123.6M |
12/31/2023 | -6.36% | $ 1.94B | $ 123.6M |
9/30/2023 | -0.16% | $ 1.46B | $ 2.4M |
6/30/2023 | -0.21% | $ 1.58B | $ 3.3M |
3/31/2023 | -0.35% | $ 1.72B | $ 6M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for MYRIAD GENETICS INC is calculated as follows: (-1 * CF - Equity [ $ 3.9M ]) / Market Cap [ $ 1.28B ]
(=) Buyback Yield [ -0.31% ]
Minimum
Sep 30, 2024
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.46% |
average | 0.64% |
median | 0.01% |
std | 2.71% |